Document Details
Form
Filing Date
Feb 23, 2023
Document Date
Feb 17, 2023
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
Kinnate Biopharma
Issuer
Kinnate Biopharma Inc.
Filer
ORBIMED ADVISORS LLC